Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2006

Open Access 01-12-2006 | Research

Quality of life in patients with various Barrett's esophagus associated health states

Authors: Chin Hur, Eve Wittenberg, Norman S Nishioka, G Scott Gazelle

Published in: Health and Quality of Life Outcomes | Issue 1/2006

Login to get access

Abstract

Background

The management of Barrett's esophagus (BE), particularly high grade dysplasia (HGD), is an area of much debate and controversy. Surgical esophagectomy, intensive endoscopic surveillance and mucosal ablative techniques, especially photodynamic therapy (PDT), have been proposed as possible management strategies. The purpose of this study was to determine the health related quality of life associated with Barrett's esophagus and many of the pivotal health states associated with Barrett's HGD management.

Methods

20 patients with Barrett's esophagus were enrolled in a pilot survey study at a large urban hospital. The utility of Barrett's esophagus without dysplasia (current health state) as well as various health states associated with HGD management (hypothetical states as the subject did not have HGD) were measured using a validated health utility instrument (Paper Standard Gamble). These specific health states were chosen for the study because they are considered pivotal in Barrett's HGD decision making. Information regarding Barrett's HGD was presented to the subject in a standardized format that was designed to be easily comprehendible.

Results

The average utility scores (0–1 with 0 = death and 1 = perfect health) for the various Barrett's esophagus associated states were: BE without dysplasia-0.95; Post-esophagectomy for HGD with dysphagia-0.92; Post-PDT for HGD with recurrence uncertainty-0.93; Post-PDT for HGD with recurrence uncertainty and dysphagia-0.91; Intensive endoscopic surveillance for HGD-0.90.

Conclusion

We present the scores for utilities associated with Barrett's esophagus as well as various states associated with the management of HGD. The results of our study may be useful in advising patients and providers regarding expected outcomes of the various HGD management strategies as well as providing utility scores for future cost-effectiveness analyses.
Appendix
Available only for authorised users
Literature
1.
Lagergren J, Bergstrom R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999,340(11):825–831. 10.1056/NEJM199903183401101PubMedCrossRef
2.
Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ: Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997,112(5):1448–1456. 10.1016/S0016-5085(97)70025-8PubMedCrossRef
3.
Devesa SS, Blot WJ, Fraumeni JFJ: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998,83(10):2049–2053. 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2PubMedCrossRef
4.
Weston AP, Sharma P, Topalovski M, Richards R, Cherian R, Dixon A: Long-term follow-up of Barrett's high-grade dysplasia. Am J Gastroenterol 2000,95(8):1888–1893. 10.1111/j.1572-0241.2000.02234.xPubMedCrossRef
5.
Edwards MJ, Gable DR, Lentsch AB, Richardson JD: The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996,223(5):585–9; discussion 589–91.. 10.1097/00000658-199605000-00014PubMedCentralPubMedCrossRef
6.
Heitmiller RF, Redmond M, Hamilton SR: Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996,224(1):66–71. 10.1097/00000658-199607000-00010PubMedCentralPubMedCrossRef
7.
Rice TW, Falk GW, Achkar E, Petras RE: Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993,88(11):1832–1836.PubMed
8.
Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC: Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 1992,54(2):199–204.PubMedCrossRef
9.
Peters JH, Clark GW, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR: Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994,108(5):813–21; discussion 821–2..PubMed
10.
Falk GW, Rice TW, Goldblum JR, Richter JE: Jumbo biopsy forceps protocol still misses unsuspected cancer in Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 1999,49(2):170–176. 10.1016/S0016-5107(99)70482-7PubMedCrossRef
11.
Stein HJ: Esophageal cancer: screening and surveillance. Results of a consensus conference held at the VIth World Congress of the International Society for Diseases of the Esophagus. Dis Esophagus 1996, 9: s3–19.
12.
Begg CB, Cramer LD, Hoskins WJ, Brennan MF: Impact of hospital volume on operative mortality for major cancer surgery. Jama 1998,280(20):1747–1751. 10.1001/jama.280.20.1747PubMedCrossRef
13.
Schnell TG, Sontag SJ, Chejfec G, Aranha G, Metz A, O'Connell S, Seidel UJ, Sonnenberg A: Long-term nonsurgical management of barrett's esophagus with high-grade dysplasia. Gastroenterology 2001,120(7):1607–1619. 10.1053/gast.2001.25065PubMedCrossRef
14.
Overholt BF, Panjehpour M, Haydek JM: Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 1999,49(1):1–7. 10.1016/S0016-5107(99)70437-2PubMedCrossRef
15.
Hur C, Nishioka NS, Gazelle GS: Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci 2003,48(7):1273–1283. 10.1023/A:1024146823549PubMedCrossRef
16.
Ross PL, Littenberg B, Fearn P, Scardino PT, Karakiewicz PI, Kattan MW: Paper standard gamble: a paper-based measure of standard gamble utility for current health. Int J Technol Assess Health Care 2003,19(1):135–147. 10.1017/S0266462303000138PubMedCrossRef
17.
Hur C, Wittenberg E, Nishioka NS, Gazelle GS: Patient preferences for the management of high-grade dysplasia in Barrett's esophagus. Dig Dis Sci 2005,50(1):116–125. 10.1007/s10620-005-1288-7PubMedCrossRef
18.
Hur C, Wittenberg E, Nishioka NS, Gazelle GS: Patient Preferences for the Management of HGD in Barrett's Esophagus. Gastroenterology 2004,126(4 Suppl 2):A-113 [Abstract].
19.
Torrance GW: Measurement of health state utilities for economic appraisal: A review. J Health Econ 1986, 5: 1–30. 10.1016/0167-6296(86)90020-2PubMedCrossRef
20.
Littenberg B, Partilo S, Licata A, Kattan MW: Paper Standard Gamble: the reliability of a paper questionnaire to assess utility. Med Decis Making 2003,23(6):480–488. 10.1177/0272989X03259817PubMedCrossRef
21.
Torrance GW, Boyle MH, Horwood SP: Application of multi-attribute utility theory to measure social preferences for health states. Oper Res 1982, 30: 1043–1069.PubMedCrossRef
22.
Furlong W FDHTGWBRHJ: Guide to Design and Development of Health-State Unitility Instrumentation. In Centre for Health Economics and Policy Analysis Working Paper Series #90–9. Hamilton, Ontario, Canada: McMaster University ; 1990.
23.
Gerson LB, Ullah N, Hastie T, Triadafilopoulos G, Goldstein M: Patient-derived health state utilities for gastroesophageal reflux disease. Am J Gastroenterol 2005,100(3):524–533. 10.1111/j.1572-0241.2005.40588.xPubMedCrossRef
24.
Fisher D, Jeffreys A, Bosworth H, Wang J, Lipscomb J, Provenzale D: Quality of life in patients with Barrett's esophagus undergoing surveillance. Am J Gastroenterol 2002,97(9):2193–2200. 10.1111/j.1572-0241.2002.05972.xPubMedCrossRef
25.
Provenzale D, Schmitt C, Wong JB: Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999,94(8):2043–2053. 10.1111/j.1572-0241.1999.01276.xPubMedCrossRef
26.
Fryback DG, Dasbach EJ, Klein R, Klein BE, Dorn N, Peterson K, Martin PA: The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 1993,13(2):89–102.PubMedCrossRef
27.
Ferguson MK, Naunheim KS: Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg 1997,114(5):824–829. 10.1016/S0022-5223(97)70087-4PubMedCrossRef
28.
Headrick JR, Nichols FC, Miller DL, Allen MS, Trastek VF, Deschamps C, Schleck CD, Thompson AM, Pairolero PC: High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 2002,73(6):1697–702; discussion 1702–3. 10.1016/S0003-4975(02)03496-3PubMedCrossRef
29.
Bueno R, Swanson SJ, Jaklitsch MT, Lukanich JM, Mentzer SJ, Sugarbaker DJ: Combined antegrade and retrograde dilation: a new endoscopic technique in the management of complex esophageal obstruction. Gastrointestinal Endoscopy 2001,54(3):368–372. 10.1067/mge.2001.117517PubMedCrossRef
30.
Hur C, Nishioka NS, Gazelle GS: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst 2004,96(4):316–325.PubMedCrossRef
31.
Barham CP, Jones RL, Biddlestone LR, Hardwick RH, Shepherd NA, Barr H: Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut 1997,41(3):281–284.PubMedCentralPubMedCrossRef
32.
Bonavina L, Ceriani C, Carazzone A, Segalin A, Ferrero S, Peracchia A: Endoscopic laser ablation of nondysplastic Barrett's epithelium: is it worthwhile? J Gastrointest Surg 1999,3(2):194–199. 10.1016/S1091-255X(99)80033-XPubMedCrossRef
33.
Sampliner RE: Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002,97(8):1888–1895. 10.1111/j.1572-0241.2002.05910.xPubMedCrossRef
Metadata
Title
Quality of life in patients with various Barrett's esophagus associated health states
Authors
Chin Hur
Eve Wittenberg
Norman S Nishioka
G Scott Gazelle
Publication date
01-12-2006
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2006
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-4-45

Other articles of this Issue 1/2006

Health and Quality of Life Outcomes 1/2006 Go to the issue

Research

Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with Pegylated interferon alpha -2b and ribavirin

Research

Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study

Research

Health-related quality of life in patients waiting for major joint replacement. A comparison between patients and population controls

Research

Validation of the Burden Index of Caregivers (BIC), a multidimensional short care burden scale from Japan

Research

Misinterpretation with norm-based scoring of health status in adults with type 1 diabetes

Research

Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients